Drug Innovation Ventures at Emory University originally developed molnupiravir to treat influenza. Mpiravir capsules- Molnupiravir 200mg is an antiviral drug that is proven to be effective in patients with mild-to-moderate COVID-19. As a result, it has decreased the risk of death or hospitalization. In the global fight against the pandemic, this oral medication in the form of capsule holds the potential to be an important medicine. Doctors can prescribe this medication to patients with COVID-19 to continue antiviral treatment at home. The capsule is meant to be taken after COVID-19 symptoms have been experienced. The dosage is also recommended by the doctor; patients must follow the instructions carefully to get results.